These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26460076)

  • 1. Expression of Lipoprotein associated phospholipase A2 enzyme in medical undergraduate students with metabolic syndrome.
    Garg S; Malik P; Kar R; Sankar V; Mehndiratta M
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S21-4. PubMed ID: 26460076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.
    Pokharel Y; Sun W; Polfus LM; Folsom AR; Heiss G; Sharrett AR; Boerwinkle E; Ballantyne CM; Hoogeveen RC
    Atherosclerosis; 2015 Aug; 241(2):641-8. PubMed ID: 26117401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players.
    Pokharel Y; Nambi V; Martin SS; Hoogeveen RC; Nasir K; Khera A; Wong ND; Jones PH; Boone J; Roberts AJ; Ballantyne CM; Virani SS
    Atherosclerosis; 2014 Oct; 236(2):251-6. PubMed ID: 25105582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study).
    Kleber ME; Wolfert RL; De Moissl GD; Grammer TB; Dietz S; Winkelmann BR; Boehm BO; März W
    Clin Lab; 2011; 57(9-10):659-67. PubMed ID: 22029180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Gestational Diabetes Mellitus increases placental and foetal lipoprotein-associated Phospholipase A2 which might exert protective functions against oxidative stress.
    Schliefsteiner C; Hirschmugl B; Kopp S; Curcic S; Bernhart EM; Marsche G; Lang U; Desoye G; Wadsack C
    Sci Rep; 2017 Oct; 7(1):12628. PubMed ID: 28974763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and lipoprotein-associated phospholipase A2 in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health study.
    Kleber ME; Siekmeier R; Delgado G; Grammer TB; Winkelmann BR; Scharnagl H; Boehm BO; März W
    Adv Exp Med Biol; 2015; 832():15-23. PubMed ID: 25300684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis.
    Winkler K; Hoffmann MM; Krane V; Drechsler C; Wanner C;
    Eur J Clin Invest; 2012 Jul; 42(7):693-701. PubMed ID: 22211481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
    Zaki M; Amr K
    Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
    Noto H; Chitkara P; Raskin P
    J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study).
    Hoffmann MM; Winkler K; Renner W; Winkelmann BR; Seelhorst U; Wellnitz B; Boehm BO; März W
    J Thromb Haemost; 2009 Jan; 7(1):41-8. PubMed ID: 18983494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 distribution among lipoproteins differs in type 1 diabetes.
    Jarvie JL; Wang H; Kinney GL; Snell-Bergeon J; Hokanson JE; Eckel RH
    J Clin Lipidol; 2016; 10(3):577-86. PubMed ID: 27206945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a single hemodialysis session on inflammatory markers.
    Bitla AR; Reddy PE; Manohar SM; Vishnubhotla SV; Pemmaraju Venkata Lakshmi Narasimha SR
    Hemodial Int; 2010 Oct; 14(4):411-7. PubMed ID: 20955274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A2 activity in patients with preserved left ventricular ejection fraction.
    Moldoveanu E; Serban M; Marta DS; Serban I; Huica R
    Biomarkers; 2011 Nov; 16(7):587-9. PubMed ID: 21942556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2, myeloperoxidase and vascular endothelial growth factor - predictors of high vascular risk in respiratory bacterial infections.
    Seri A; Marta DS; Madalan A; Popescu M; Tiglea AI; Moldoveanu E
    J Med Life; 2016; 9(4):429-433. PubMed ID: 27928450
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of renin-angiotensin-aldosterone system activation and other metabolic variables in relation to arterial inflammation in HIV.
    Shen G; Thomas TS; Walpert AR; McClure CM; Fitch KV; deFilippi C; Torriani M; Buckless CG; Adler GK; Grinspoon SK; Srinivasa S
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):581-587. PubMed ID: 35614846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of the arterial wall in patients with low and moderate risk by SCORE scale].
    Urazalina SZh; Titov VN; Vlasik TN; Balakhonova TV; Karpov IuA; Kukharchuk VV; Boĭtsov SA
    Ter Arkh; 2011; 83(9):29-35. PubMed ID: 22145385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].
    Jia ZR; Zhao D; Qi Y; Wang W; Wang M; Sun JY; Qin LP; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):962-7. PubMed ID: 24370228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study.
    Katan M; Moon YP; Paik MC; Wolfert RL; Sacco RL; Elkind MS
    PLoS One; 2014; 9(1):e83393. PubMed ID: 24416164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
    Tsimikas S; Tsironis LD; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.